Similar articles

• [beta2-Sympathomimetics: dangers in asthma therapy? Lessons from the SMART1 Study].

  Riedl-Seifert R. Riedl-Seifert R. Dtsch Med Wochenschr. 2007 Mar 23;132(12):633; author reply 633-4. doi: 10.1055/s-2007-973592. Dtsch Med Wochenschr. 2007. PMID: 17357910 German. No abstract available.
• [Drugs for the treatment of asthma].

  Collins-Williams C. Collins-Williams C. Alergia. 1977 Jan;24(1):29-38. Alergia. 1977. PMID: 855906 Spanish. No abstract available.
• [Treatment of asthma; are there still questions?].

  van Schayck CP. van Schayck CP. Ned Tijdschr Geneeskd. 1996 Jan 13;140(2):72-7. Ned Tijdschr Geneeskd. 1996. PMID: 8569925 Review. Dutch. No abstract available.
• Changes in recommended treatments for mild and moderate asthma.

  Redding GJ, Stoloff SW. Redding GJ, et al. J Fam Pract. 2004 Sep;53(9):692-700. J Fam Pract. 2004. PMID: 15353157 Review. No abstract available.
• Practical therapeutics current concepts in management of bronchial asthma.

  Obel AO. Obel AO. East Afr Med J. 1981 May;58(5):311-7. East Afr Med J. 1981. PMID: 6116589 No abstract available.